Publication | Open Access

A phase II evaluation of lapatinib in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: A gynecologic oncology group study

Primary Peritoneal CarcinomaPhase Ii EvaluationMedicineRecurrent Epithelial OvarianCancer ManagementGynecologyCancer TreatmentOncologyRadiation OncologyGynecology OncologyMolecular OncologyOvarian Cancer